Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.60 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.59 |
| ▸ | LTA4H | P09960 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29622860 | 0.99 | TRPV1 (0.62) | TRPV1DPP7LTA4HALDH1A1HPGD | |
| SCHEMBL29540555 | 0.84 | DPP7 (0.59) | TRPV1DPP7ALDH1A1HPGD | |
| SCHEMBL29384564 | 0.83 | DPP7 (0.58) | TRPV1DPP7ALDH1A1HPGD | |
| SCHEMBL2043178 | 0.80 | MEN1 (0.61) | DPP7ALDH1A1HPGDSMN1; SMN2MEN1 | |
| SCHEMBL9425805 | 0.80 | TRPV1 (0.81) | TRPV1ALDH1A1HPGDSMN1; SMN2MEN1 | |
| SCHEMBL8843511 | 0.79 | DPP7 (0.59) | DPP7ALDH1A1HPGDSMN1; SMN2MEN1 | |
| SCHEMBL9425973 | 0.78 | TRPV1 (0.83) | TRPV1ALDH1A1HPGDSMN1; SMN2MEN1 | |
| SCHEMBL18313841 | 0.77 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL6295177 | 0.76 | MEN1 (0.59) | DPP7ALDH1A1HPGDSMN1; SMN2MEN1 | |
| SCHEMBL109279 | 0.76 | ALDH1A1 (0.67) | DPP7ALDH1A1HPGDSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119986166-A | Electrical sensor assembly | G&W电气公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-113227802-B | Electrical sensor assembly | G&W电气公司 | 2025-02-11 | — | — | CN | disclosed |
| US-20240376058-A1 | GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF | DECIPHERA PHARMACEUTICALS, LLC | 2024-11-14 | — | — | US | disclosed |
| US-20240336700-A1 | ANTIGEN-BINDING POLYPEPTIDES DIRECTED AGAINST CD38 | UNIVERSITY MEDICAL CENTER HAMBURG-EPPENDORF (DE) | 2024-10-10 | — | — | US | disclosed |
| US-12018088-B2 | Antigen-binding polypeptides directed against CD38 | UNIVERSITY MEDICAL CENTER HAMBURG-EPPENDORF (DE) | 2024-06-25 | — | — | US | disclosed |
| US-20240196931-A1 | BOTANICAL SUPPLEMENT AND METHOD FOR PREVENTING DISEASES, PROMOTING GROWTH AND SURVIVAL OF AN ANIMAL BY USING THE SAME | ACADEMIA SINICA (TW) | 2024-06-20 | — | — | US | disclosed |
| US-11912668-B2 | GCN2 and perk kinase inhibitors and methods of use thereof | DECIPHERA PHARMACEUTICALS, LLC (US) | 2024-02-27 | — | — | US | disclosed |
| CN-117599850-A | Nano composite material of fullerene/photosensitizer, preparation method and application thereof | 中国科学院化学研究所 | 2024-02-27 | — | — | CN | disclosed |
| US-11774481-B2 | Electrical sensor assembly | G & W ELECTRIC COMPANY (US) | 2023-10-03 | — | — | US | disclosed |
| EP-4247795-A1 | GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF | Deciphera Pharmaceuticals, LLC (US) | 2023-09-27 | — | — | EP | disclosed |
| CN-113603877-B | Functionalized diblock copolymer, preparation method and application thereof | 亭创生物科技(上海)有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-114990168-B | Composition prepared by fermenting sour cherry and having good health care function and application of composition in health field | 灶灶科技有限公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-111662341-B | Method for oxidative depolymerization of lignin and application thereof | 东南大学 | 2023-01-31 | — | — | CN | disclosed |
| US-20220357382-A1 | ELECTRICAL SENSOR ASSEMBLY | G & W ELECTRIC COMPANY | 2022-11-10 | — | — | US | disclosed |
| CN-114990168-A | Composition prepared by fermenting sour cherry and having good health care function and application thereof in health field | 清枫链食苏打饮品(吉林)有限公司 | 2022-09-02 | — | — | CN | disclosed |
| US-20220274934-A1 | GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF | DECIPHERA PHARMACEUTICALS, LLC | 2022-09-01 | — | — | US | disclosed |
| US-11346876-B2 | Electrical sensor assembly | G & W ELECTRIC COMPANY (US) | 2022-05-31 | — | — | US | disclosed |
| WO-2022109001-A1 | GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF | DECIPHERA PHARMACEUTICALS, LLC (US) | 2022-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240376058-A1 | GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF | EIF2AK4, GCN1, EEF2K | TRPV1 4394/4885DPP7 1895/4885LTA4H 3770/4885 |
| US-20220274934-A1 | GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF | EIF2AK4, GCN1, EEF2K | TRPV1 4394/4885DPP7 1895/4885LTA4H 3770/4885 |
| US-11912668-B2 | GCN2 and perk kinase inhibitors and methods of use thereof | EIF2AK4, GCN1, MAPKAPK2 | TRPV1 4049/4885DPP7 3787/4885LTA4H 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.